Evaxion Biotech (EVAX)
NASDAQ:EVAX

Evaxion Biotech Stock Analysis & Ratings

EVAX Stock Chart & Stats

Day’s Range$1.7 - $1.85
52-Week Range$1.51 - $25.04
Previous Close$1.81
Volume46.31K
Average Volume (3M)299.08K
Market Cap$42.46M
P/E Ratio-1.5
Beta-0.12
Next EarningsAug 11, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart Score1
EPS (TTM)-1.25


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

EVAX FAQ

What was Evaxion Biotech’s price range in the past 12 months?
Evaxion Biotech lowest stock price was $1.51 and its highest was $25.04 in the past 12 months.
    What is Evaxion Biotech’s market cap?
    Evaxion Biotech’s market cap is $42.46M.
      What is Evaxion Biotech’s price target?
      Currently, no data Available
      What do analysts say about Evaxion Biotech?
      Not enough analysts have published a price target to provide an average price target.
      When is Evaxion Biotech’s upcoming earnings report date?
      Evaxion Biotech’s upcoming earnings report date is Aug 11, 2022 which is in 82 days.
        How were Evaxion Biotech’s earnings last quarter?
        Evaxion Biotech released its earnings results on May 11, 2022. The company reported -$0.25 earnings per share for the quarter, beating the consensus estimate of -$0.327 by $0.077.
          Is Evaxion Biotech overvalued?
          According to Wall Street analysts Evaxion Biotech’s price is currently Overvalued.
            Does Evaxion Biotech pay dividends?
            Evaxion Biotech does not currently pay dividends.
            What is Evaxion Biotech’s EPS estimate?
            Evaxion Biotech’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Evaxion Biotech have?
            Evaxion Biotech has 23,200,000 shares outstanding.
              What happened to Evaxion Biotech’s price movement after its last earnings report?
              Evaxion Biotech reported an EPS of -$0.25 in its last earnings report, beating expectations of -$0.327. Following the earnings report the stock price went down -15.111%.
                Which hedge fund is a major shareholder of Evaxion Biotech?
                Currently, no hedge funds are holding shares in EVAX

                ---

                Evaxion Biotech Stock Analysis

                Smart Score
                1
                Underperform
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10
                Price Target
                No data currently available
                The Evaxion Biotech stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Evaxion Biotech

                Evaxion Biotech AS is an artificial intelligence immunology platform company. It uses proprietary AI technology, engineering expertise and drug development know-how to simulate the human immune system and generate predictive models to identify and develop efficacious immunotherapies for patients in the global market.

                ---
                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis